Arcellx Stock Investor Sentiment

ACLX Stock  USD 68.13  0.55  0.81%   
Slightly above 56% of Arcellx's investor base is looking to short. The analysis of the overall investor sentiment regarding Arcellx suggests that many traders are alarmed. Arcellx's investing sentiment can be driven by a variety of factors including economic data, Arcellx's earnings reports, geopolitical events, and overall market trends.

Panic Vs Confidence

44

 
Panic
 
Confidence
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Arcellx's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Arcellx.

Arcellx Historical Sentiment

Although Arcellx's investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding Arcellx, such as negative comments on social media and news outlets, may cause fear in the market and push Arcellx's investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of Arcellx.
  

Arcellx Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Arcellx can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Arcellx Historical Investor Sentiment

Investor biases related to Arcellx's public news can be used to forecast risks associated with an investment in Arcellx. The trend in average sentiment can be used to explain how an investor holding Arcellx can time the market purely based on public headlines and social activities around Arcellx. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Arcellx's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Arcellx and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Arcellx news discussions. The higher the estimate score, the more favorable the investor's outlook on Arcellx.

Arcellx Maximum Pain Price Across April 17th 2025 Option Contracts

Arcellx's options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of Arcellx close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of Arcellx's options.
few days ago at news.google.com         
Arcellx, Inc. Given Average Rating of Buy by Brokerages - MarketBeat
Google News at Macroaxis
six days ago at news.google.com         
Stifel maintains Buy on Arcellx shares, target at 122 - Investing.com
Google News at Macroaxis
over two weeks ago at www.macroaxis.com         
Disposition of 3421 shares by Heery Christopher of Arcellx at 15.0 subject to Rule 16b-3
Macroaxis News
over two weeks ago at zacks.com         
Adaptive Biotechnologies Soars 18.0 percent Is Further Upside Left in the Stock?
zacks News
over two weeks ago at www.macroaxis.com         
Disposition of 300 shares by Patel Kavita of Arcellx at 67.3167 subject to Rule 16b-3
Macroaxis News
over three weeks ago at news.google.com         
arcellx CEO Elghandour sells stock worth 2.26 million - Investing.com
Google News at Macroaxis
over three weeks ago at www.macroaxis.com         
Disposition of 1061 shares by Michelle Gilson of Arcellx at 87.89 subject to Rule 16b-3
Macroaxis News
over three weeks ago at www.macroaxis.com         
Disposition of 13837 shares by Rami Elghandour of Arcellx at 73.6929 subject to Rule 16b-3
Macroaxis News
over three weeks ago at zacks.com         
Disposition of 16474 shares by Rami Elghandour of Arcellx at 75.5283 subject to Rule 16b-3
zacks News
over three weeks ago at zacks.com         
Guardant Health Soars 6.3 percent Is Further Upside Left in the Stock?
zacks News
over three weeks ago at www.macroaxis.com         
Disposition of 13776 shares by Rami Elghandour of Arcellx at 77.1668 subject to Rule 16b-3
Macroaxis News
over three weeks ago at news.google.com         
Arcellx, Inc. Receives 105.93 Consensus Price Target from Analysts - MarketBeat
Google News at Macroaxis
over a month ago at www.macroaxis.com         
Disposition of 53097 shares by Rami Elghandour of Arcellx subject to Rule 16b-3
Macroaxis News
over a month ago at www.macroaxis.com         
Disposition of 55459 shares by Rami Elghandour of Arcellx subject to Rule 16b-3
Macroaxis News
over a month ago at thelincolnianonline.com         
Kavita Patel Sells 1,500 Shares of Arcellx, Inc. Stock
news
Far too much social signal, news, headlines, and media speculation about Arcellx that are available to investors today. That information is available publicly through Arcellx media outlets and privately through word of mouth or via Arcellx internal channels. However, regardless of the origin, that massive amount of Arcellx data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Arcellx news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Arcellx relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Arcellx's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Arcellx alpha.

Arcellx Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Arcellx Releases Clinical Data from Phase 1 and iMMagine-1 Studies for Multiple Myeloma Patients On November 5, 2024, Arcellx, Inc. made public an abstract cont...
11/05/2024
2
Disposition of 3005 shares by Patel Kavita of Arcellx at 106.9083 subject to Rule 16b-3
11/11/2024
3
arcellx director Kavita Patel sells 159,495 in stock
11/14/2024
4
Acquisition by Michelle Gilson of 3000 shares of Arcellx at 8.66 subject to Rule 16b-3
11/19/2024
5
Disposition of 400 shares by Patel Kavita of Arcellx at 89.8425 subject to Rule 16b-3
12/06/2024
6
Arcellx Announces New Positive Data for Its iMMagine-1 Study in Patients With Relapsed or Refractory Multiple Myeloma to be Presented During an Oral Presentatio...
12/09/2024
7
Arcellx, Inc. Given Consensus Rating of Buy by Analysts
12/11/2024
8
Risks To Shareholder Returns Are Elevated At These Prices For Arcellx, Inc.
12/20/2024
9
Disposition of 100 shares by Patel Kavita of Arcellx at 77.61 subject to Rule 16b-3
12/24/2024
10
Stocks Showing Rising Market Leadership Arcellx Earns 82 RS Rating - Investors Business Daily
12/27/2024
11
Disposition of 55459 shares by Rami Elghandour of Arcellx subject to Rule 16b-3
01/02/2025
12
Disposition of 53097 shares by Rami Elghandour of Arcellx subject to Rule 16b-3
01/03/2025
13
Disposition of 13776 shares by Rami Elghandour of Arcellx at 77.1668 subject to Rule 16b-3
01/06/2025
14
Disposition of 16474 shares by Rami Elghandour of Arcellx at 75.5283 subject to Rule 16b-3
01/07/2025
15
Disposition of 1061 shares by Michelle Gilson of Arcellx at 87.89 subject to Rule 16b-3
01/08/2025
16
Disposition of 300 shares by Patel Kavita of Arcellx at 67.3167 subject to Rule 16b-3
01/14/2025
17
Adaptive Biotechnologies Soars 18.0 percent Is Further Upside Left in the Stock
01/16/2025
18
Disposition of 3421 shares by Heery Christopher of Arcellx at 15.0 subject to Rule 16b-3
01/17/2025
19
Arcellx, Inc. Given Average Rating of Buy by Brokerages - MarketBeat
01/30/2025

Additional Tools for Arcellx Stock Analysis

When running Arcellx's price analysis, check to measure Arcellx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arcellx is operating at the current time. Most of Arcellx's value examination focuses on studying past and present price action to predict the probability of Arcellx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arcellx's price. Additionally, you may evaluate how the addition of Arcellx to your portfolios can decrease your overall portfolio volatility.